Description
Description
Retatrutide (50mg) is a high-concentration triple agonist targeting GIP, GLP-1, and glucagon receptors. This formulation supports large-scale metabolic research projects.
Research Applications
Studies focus on the biological impact of intensive triple receptor activation on metabolic pathways.
Reviews
There are no reviews yet.